In vitro and in vivo evaluation of oral hepariri~lc!ùiléit~p6iymeric nanoparticles in rabbits Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study, Circulation J Control Release, vol.105, issue.3 22, pp.0-5, 2002. ,
???Stealth??? corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids and Surfaces B: Biointerfaces, vol.18, issue.3-4, pp.3-4, 2000. ,
DOI : 10.1016/S0927-7765(99)00156-3
Visualization of in vitro protein-rejecting properties of PEGylated stealth?? polycyanoacrylate nanoparticles, Biomaterials, vol.20, issue.14, pp.1269-75, 1999. ,
DOI : 10.1016/S0142-9612(99)00021-6
Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators, Biomaterials, vol.17, issue.16, pp.17-1575, 1996. ,
DOI : 10.1016/0142-9612(95)00322-3
Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system, Life Sciences, vol.62, issue.8, pp.62-775, 1998. ,
DOI : 10.1016/S0024-3205(97)01175-2
Heparin-like polymer surfaces: control of coagulation and complement activation by insoluble functionalized polymers, Int J Artif Organs, issue.10, pp.13-651, 1990. ,
Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition, The Annals of Thoracic Surgery, vol.78, issue.1, pp.38-44, 2004. ,
DOI : 10.1016/j.athoracsur.2004.02.005
Dextrans for targeted and sustained delivery of therapeutic and imaging agents, Journal of Controlled Release, vol.69, issue.1, pp.1-25, 2000. ,
DOI : 10.1016/S0168-3659(00)00302-3
Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer???doxorubicin conjugates in nude mice, European Journal of Cancer, vol.37, issue.1, pp.131-140, 2001. ,
DOI : 10.1016/S0959-8049(00)00374-9
Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA???PEG block copolymer, Journal of Controlled Release, vol.70, issue.1-2, pp.63-70, 2001. ,
DOI : 10.1016/S0168-3659(00)00340-0
Molecular design of polyvinylpyrrolidone-conjugated interleukin-6 for enhancement of in vivo thrombopoietic activity in mice, Journal of Controlled Release, vol.68, issue.3, pp.335-376, 2000. ,
DOI : 10.1016/S0168-3659(00)00249-2
PEG drugs: an overview, Journal of Controlled Release, vol.74, issue.1-3, pp.159-71, 2001. ,
DOI : 10.1016/S0168-3659(01)00331-5
A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain, Journal of Controlled Release, vol.22, issue.2, pp.141-157, 1992. ,
DOI : 10.1016/0168-3659(92)90199-2
Block copolymer micelles as long-circulating drug vehicles, Advanced Drug Delivery Reviews, vol.16, issue.2-3, pp.295-309, 1995. ,
DOI : 10.1016/0169-409X(95)00031-2
Les formes vectoriséesou à distribution modulée, nouveaux systèmes d'administration des médicaments, J. Pharm. Belg, vol.17, issue.5, pp.319-329, 1986. ,
Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy, International Journal of Pharmaceutics, vol.312, issue.1-2, pp.105-117, 2006. ,
DOI : 10.1016/j.ijpharm.2006.01.002
Liposomes coated with chemically modified dextran interact with human endothelial cells, Journal of Biomedical Materials Research, vol.280, issue.2, pp.140-148, 1999. ,
DOI : 10.1016/0304-4165(94)00163-R
Interactions between liposomes and chitosan, International Journal of Pharmaceutics, vol.101, issue.3, pp.227-236, 1994. ,
DOI : 10.1016/0378-5173(94)90218-6
Preparation of redispersible dry emulsions by spray drying, International Journal of Pharmaceutics, vol.212, issue.2, pp.187-194, 2001. ,
DOI : 10.1016/S0378-5173(00)00596-2
Solid state characterisation of a dry emulsion: a potential drug delivery system, International Journal of Pharmaceutics, vol.171, issue.2, pp.257-270, 1998. ,
DOI : 10.1016/S0378-5173(98)00197-5